Nakagawa-Nagahama, Yoshiko
Igarashi, Masaki
Miura, Masaomi
Kashiwabara, Kosuke
Yaku, Keisuke
Fukamizu, Yuichiro
Sato, Toshiya
Sakurai, Takanobu
Nakagawa, Takashi
Kadowaki, Takashi
Yamauchi, Toshimasa
Funding for this research was provided by:
Mitsubishi Corporation Life Sciences Limited
Article History
Received: 30 October 2022
Accepted: 3 February 2023
First Online: 15 February 2023
Declarations
:
: The study was approved by the Graduate School of Medicine and Faculty of Medicine, University of Tokyo Research Ethics Committee (2018013P) and registered as “Randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the effect of nicotinamide mononucleotide (NMN) on the body composition in elderly persons” at UMIN-CTR (UMIN000036321). All participants provided written informed consent to participate in the study.
: Not applicable.
: Funding from Mitsubishi Corporation Life Sciences Limited is gratefully acknowledged. YF, TSato, and TSakurai declare no competing non-financial interests however declare the following competing financial interests: they are employees of Mitsubishi Corporation Life Sciences Limited. The other authors have no conflicts of interest to declare.